Original Air Date: April 22, 2026
Summary
Join Chubb for an informative session designed to help agents and brokers understand the complexities of FDA enforcement and guide their clients in mitigating the impacts to product liability insurance.
Key topics include:
- What underwriters prioritize when evaluating FDA-regulated businesses
- The impact of FDA warning letters on operations, reputation and insurability
- How enforcement actions can affect a company’s risk profile and business continuity
- The role of a robust Corrective and Preventive Action (CAPA) program in avoiding common compliance pitfalls
Don’t miss this opportunity to stay ahead of regulatory exposures and strengthen your clients’ preparedness.